Kalyan Capitals Limited (KALYANCAP.BO)
INR 13.4
(0.0%)
INR 13.4
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 66.89 Million | 20.04 Million | 665.97 Million | 7.98 Million | 22.22 Million |
| Net Income | 60.05 Million | 35.58 Million | 21.65 Million | 7.98 Million | 22.22 Million |
| Depreciation & Amortization | 6.27 Million | 3.26 Million | 2.37 Million | 1.52 Million | 1.09 Million |
| Deferred income taxes | - | - | 47 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 306 Thousand | -22.46 Million | 635.42 Million | - | - |
| Other non-cash items | 12.81 Million | 10.19 Million | 11.27 Million | -1.52 Million | -1.09 Million |
| Investing Cash Flow | -341.1 Million | -247.72 Million | -665.72 Million | - | - |
| Investments in PPE | -18.79 Million | -2.91 Million | -6.83 Million | - | - |
| Acquisitions | 22.97 Million | 3.31 Million | 6.39 Million | - | - |
| Investment purchases | -328.44 Million | -16.71 Million | -12.5 Million | - | - |
| Sales/Maturities of investments | 289.82 Million | - | - | - | - |
| Other Investing Activities | -306.65 Million | -231.4 Million | -652.78 Million | - | - |
| Financing Cash Flow | 294.47 Million | 228.75 Million | -972 Thousand | - | - |
| Debt repayment | -294.47 Million | -152.75 Million | -972 Thousand | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 76 Million | - | - | - |
| Other Financing Activities | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 306 Thousand | -22.46 Million | 635.42 Million | - | - |
| Cash at beginning of period | 2.55 Million | 1.47 Million | 2.2 Million | 6.68 Million | -15.53 Million |
| Cash at end of period | 22.81 Million | 2.55 Million | 1.47 Million | 2.2 Million | 6.68 Million |
| Capital Expenditure | -18.79 Million | -2.91 Million | -6.83 Million | - | - |
| Effect of forex changes on cash | - | - | 1030.00 | - | - |
| Net cash flow / Change in cash | 20.26 Million | 1.07 Million | -726.97 Thousand | -4.48 Million | 22.22 Million |
| Free Cash Flow | 48.09 Million | 17.13 Million | 659.13 Million | 7.98 Million | 22.22 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 60.05 Million | 18.03 Million | 14.89 Million | 15.17 Million | 35.58 Million | 9.49 Million |
| Depreciation & Amortization | 6.27 Million | 3.15 Million | 1.8 Million | 646 Thousand | 3.26 Million | 1.06 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 306 Thousand | - | - | - | -22.46 Million | - |
| Other non-cash items | 12.81 Million | -3.15 Million | -1.8 Million | -646 Thousand | 10.19 Million | -1.06 Million |
| Investing Cash Flow | -341.1 Million | - | - | - | -247.72 Million | - |
| Investments in PPE | -18.79 Million | - | - | - | -2.91 Million | - |
| Acquisitions | 22.97 Million | - | - | - | 3.31 Million | - |
| Investment purchases | -328.44 Million | - | - | - | -16.71 Million | - |
| Sales/Maturities of investments | 289.82 Million | - | - | - | - | - |
| Other Investing Activities | -306.65 Million | - | - | - | -231.4 Million | - |
| Financing Cash Flow | 294.47 Million | - | - | - | 228.75 Million | - |
| Debt repayment | -294.47 Million | - | - | - | -152.75 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 76 Million | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 306 Thousand | - | - | - | -22.46 Million | - |
| Cash at beginning of period | 2.55 Million | 629.25 Million | 614.35 Million | 2.55 Million | 1.47 Million | -6.94 Million |
| Cash at end of period | 22.81 Million | 18.03 Million | 629.25 Million | 15.17 Million | 2.55 Million | 2.55 Million |
| Capital Expenditure | -18.79 Million | - | - | - | -2.91 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 20.26 Million | -611.22 Million | 14.89 Million | 12.62 Million | 1.07 Million | 9.49 Million |
| Free Cash Flow | 48.09 Million | 18.03 Million | 14.89 Million | 15.17 Million | 17.13 Million | 9.49 Million |
BIOL
1072
DOTZ3
EQTRF
9435
PZOL